Phase 1 Graft Failure Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

Sickle Cell DiseaseGraft FailureHematopoetic Stem Cell Transplant+2 more

Arkansas Children's Hospital Research Institute24 enrolled4 locationsNCT07252050

Recruiting

Phase 1

REVEAL Biomarkers of Engraftment After Alternative Donor HSCT

primary graft failure

University of Oklahoma56 enrolled4 locationsNCT03541889